
2120. thioguanine treatment certain autoimmune, immunologic 
related diseases 
therapeutic effectiveness 6-thioguanine evaluated past 
3 years 19 patients diverse syndromes.  patients severe 
debilitating disease unresponsive conventional therapy treated. 
remissions occurred 2 5 patients systemic lupus erythematosus, 1 
patient dermatomyositis necrotizing angiitis, 2 patients 
psoriasis 2 4 patients atopic disease.  improvement occurred 
patients diseases 2 4 patients 
neurodermatitis.  two patients scleroderma experienced 
equivocal benefit.  significant toxicity attributable drug 
observed 5 patients.  assessment eventual value 
agents therapy requires study.  hypotheses regarding 
mechanism action agents significance clinical 
response discussed. 
